Milota Kaluzova, PhD

Research Teaching Specialist I, Center for Healthy Aging Research,
Rutgers Institute for Health, Health Care Policy and Aging Research

Milota Kaluzová, PhD is a Research Teaching Specialist I in the Department of Neurology at Rutgers University Robert Wood Johnson Medical School. She works under the supervision of William T. Hu, where her research focuses on neurodegeneration, immune profiling, and biomarker discovery in Alzheimer’s disease, frontotemporal lobar degeneration, and Long COVID. Her current work includes single-cell RNA sequencing of cerebrospinal fluid and blood samples to characterize immune signatures associated with neurological disease.

Dr. Kaluzová received her PhD in Virology and Molecular Biology from the Slovak Academy of Sciences and completed postdoctoral training in molecular genetics and pharmacology. She has held research appointments at leading institutions including University of California, Irvine and Emory University, where she conducted seminal work in hypoxia signaling, circadian rhythm regulation, cancer biology, and targeted therapies for glioblastoma and melanoma brain metastases.

Her research contributions span tumor hypoxia (HIF signaling and carbonic anhydrase IX), p53 regulation, circadian transcriptional control via CLOCK and SIRT1, tumor-associated macrophage signaling in glioblastoma, and nanoparticle-based targeted cancer therapies. Dr. Kaluzová has authored more than 77 peer-reviewed publications, with over 6,400 citations, and is an equally contributing author on a highly cited Cell publication. She is an active member of the AACR and the Society for Neuro-Oncology and has extensive experience mentoring graduate and undergraduate trainees.